Beta Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
IMMUNETHEP is a biotechnology company, spun off from the University of Porto, developing immunology-based technology originating from the Laboratory of Immunology of ICBAS.
BiotechHealthtechCantanhede, PT
Pedro Madureira(Founder & CSO)inBruno Santos(CEO)in
Co-investorsPortugal VenturesVenture Catalysts
Vawlt provides a multicloud data storage and security solution that moves company data to the cloud across multiple providers (cloud-of-clouds), aimed at organizations seeking greater data control and security.
Cloud ComputingCybersecurityData & InfrastructureLisbon, PT
Ricardo Mendes(Co-Founder & CEO)inTiago Oliveira(Co-Founder & CTO)inAlysson Bessani(Co-Founder & Tech. Advisor)in
Co-investorsArmilar Venture PartnersBasinghall PartnersLince CapitalShilling VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.